Comparison of Sexual Dysfunction in Male Schizophrenic Patients Maintained on Treatment With Classical Antipsychotics Versus Clozapine
J Clin Psychiatry 2001;62:541-544
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Antipsychotic treatment is
frequently associated with sexual dysfunction. The objective of
the present study was to evaluate and compare sexual function and
behavior in male schizophrenic patients who regularly take either
classical neuroleptic drugs or the prototypical atypical
antipsychotic agent, clozapine.
Method: Participants included 60 schizophrenic
male patients (DSM-IV criteria); 30 maintained on treatment with
classical antipsychotics and 30 on treatment with clozapine. The
patients were evaluated with a detailed 18-item sexual function
Results: Both groups reported sexual
dysfunction, although scores were significantly higher,
indicating better functioning, in the clozapine-treated group in
the domains of orgasmic function (number of orgasms per month, p
= .037; frequency of orgasm during sex, p = .046), enjoyment of
sex (p = .013), and sexual satisfaction (p = .0004). Equivocal
results were obtained for the desire parameters.
Conclusion: Maintenance therapy with the
atypical neuroleptic clozapine may be associated with a lesser
degree of sexual dysfunction than the classical antipsychotics in
male outpatients with chronic schizophrenia.